Welcome to the CEO Roundtable on Cancer

Alphanumeric Systems, Jasper Health, Shaw University Recognized for Commitment to Health

Customer service and patient experience expert Alphanumeric Systems, digital patient guide Jasper Health, and Shaw University, the oldest Historically Black College and University in the South, all have earned CEO Cancer Gold StandardTM accreditation by the CEO Roundtable on Cancer for their commitment to the health of employees, students and community.

Learn more
5 New Companies Join CEORT Mission to Reduce Cancer’s Toll

Five new companies have joined the CEO Roundtable on Cancer and its campaign to do something more about cancer prevention, diagnosis, and treatment for their employees, their families, and their communities. The companies are Elligo Health Research®, an accelerator for clinical trials important to cancer care; Black Diamond Therapeutics, a precision oncology medicine company pioneering the discovery and development of therapies for genetically defined cancers with limited treatment options; Change Healthcare, a leading healthcare technology company focused on insights, innovation, and accelerating the transformation of the U.S. healthcare system; Jasper Health, developer of a digital guide for cancer patients; and B&C International, a global business management and consulting firm.

Learn More
Ponce Health Sciences University is First HSI To Go for Gold

Ponce Health Sciences University (PHSU) in Ponce, Puerto Rico, has committed to Going for Gold, becoming the first Hispanic Serving Institution (HSI) in the partnership. “At Ponce Health Sciences University, we are honored to be part of this prestigious partnership that will allow us to continue contributing to improving the health of our communities. With this alliance, we confirm our commitment to continue our efforts to prevent and reduce cancer health disparities in the communities we serve,” said Dr. José A. Torres Ruiz, Chancellor of Ponce Health Sciences University.

Read More
FDA Renews Public Private Partnership With PDS

The US Food and Drug Administration (FDA) has reaffirmed a Public-Private Partnership (PPP) with Project Data Sphere (PDS). Scientific engagement with the FDA has been foundational to PDS and, through our seven-year symposium series together, we have identified a number of areas at the frontier of analytics and regulatory science that PDS has developed into multi-institutional research programs.

Read More

Our Mission

The mission of the CEO Roundtable on Cancer is to make continual progress toward the elimination of cancer as a personal disease and public health problem through initiatives that reduce the risk of cancer, enable early diagnosis, facilitate access to treatment, and hasten the discovery of effective therapies.

Workplace Wellness

A workplace wellness accreditation program designed to encourage healthy behaviors and improve health outcomes for employees by promoting prevention measures, encouraging early detection through cancer screenings, and ensuring access to quality care.

Research Innovation

Life sciences initiatives that bring together oncology, biotechnology and pharmaceutical companies to collaborate on removing obstacles and finding new ways to accelerate discovery and development of new therapies for cancer patients.

Global Cancer Control

Programs that catalyze progress in employee health at a global level and provide an environment that enables the compilation of historical oncology clinical trial data that will open new avenues of research.

Data Platform continuously improving

Researchers who have not logged on to the Project Data Sphere data platform recently are invited to check out all the improvements we’ve been making to respond to user feedback. Data accessed via the platform has contributed to at least 138 peer-reviewed publications and 15 associated with research programs.

Learn more

September is Prostate Cancer Awareness Month

Prostate cancer is the most common cancer and the second leading cause of cancer death among men in the United States. In the U.S., about one out of every 8 men will be diagnosed with prostate cancer. Most men diagnosed with prostate cancer do not die of it.

Avoiding cancer risk factors may help prevent certain cancers. Risk factors include smoking, being overweight, and not getting enough exercise. Increasing protective factors such as quitting smoking and exercising may also help prevent some cancers. Gold Standard employers understand prevention is much better than treatment!

Learn More